{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:38:12Z","timestamp":1787071092067,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To investigate the effects of iodine-125 seed brachytherapy (ISB) on the overall survival (OS) of patients with heterochronous pulmonary metastasis (HPM) secondary to hepatocellular carcinoma (HCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      The clinical and imaging data of 123 patients with HPM secondary to HCC treated at a single center from July 2012 to July 2020 were analyzed retrospectively. The patients were divided into ISB and non-ISB groups based on ISB treatment. Propensity score matching yielded 46 pairs of patients. A total of 191 lesions were treated, and the data were evaluated for 6 months after ISB. The OS rates of the two groups were compared using the\n                      <jats:italic toggle=\"yes\">Kaplan\u2013Meier<\/jats:italic>\n                      method. Independent prognostic factors were determined using a Cox proportional hazards regression model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The percentages of lung lesions in complete remission, partial remission, disease stable, and disease progression stages were 49.2%, 32.8%, 9.6%, and 8.4%, respectively. The disease control rate was 91.6%. The median follow-up time from the initial diagnosis was 47 months and 33 months for the ISB and non-ISB groups, respectively. Patients in the ISB group had a longer OS than those in the non-ISB group (1-year: 95.7% vs. 80.3%; 3-year: 62.9% vs. 45.7%; 5-year: 37% vs. 20.9%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Multivariate analysis demonstrated that ISB treatment, tumor differentiation, vascular invasion, and Child \u2212 Pugh score were independent prognostic factors for survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>ISB improves local control and OS rates of HPM secondary to HCC; thus, it is an effective and feasible option for patients with HPM secondary to HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_519_22","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T12:03:27Z","timestamp":1693224207000},"page":"957-963","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Effects of iodine-125 seed brachytherapy on patients with heterochronous pulmonary metastasis from hepatocellular carcinoma: A propensity score matching study"],"prefix":"10.4103","volume":"19","author":[{"given":"Chongshuang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Radiology, Tongren People\u2019s Hospital, Tongren, China"},{"name":"Department of the Minimally Invasive Intervention and Radioactive Particle Diagnosis and Treatment Center, The First Affiliated Hospital of Army Medical University, Army Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"He","sequence":"additional","affiliation":[{"name":"Department of the Minimally Invasive Intervention and Radioactive Particle Diagnosis and Treatment Center, The First Affiliated Hospital of Army Medical University, Army Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Army Medical Center, Army Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of the Minimally Invasive Intervention and Radioactive Particle Diagnosis and Treatment Center, The First Affiliated Hospital of Army Medical University, Army Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuequan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of the Minimally Invasive Intervention and Radioactive Particle Diagnosis and Treatment Center, The First Affiliated Hospital of Army Medical University, Army Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5761\/atcs.ra.18-00229","article-title":"The past, present and future of pulmonary metastasectomy:A review article","volume":"25","author":"Cheung","year":"2019","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.12659\/MSM.913470","article-title":"Advanced hepatocellular carcinoma with bone metastases:Prevalence, associated factors, and survival estimation","volume":"25","author":"Guo","year":"2019","journal-title":"Med Sci Monit"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1002\/cncr.25960","article-title":"Hepatocellular carcinoma with extrahepatic metastasis:Clinical features and prognostic factors","volume":"117","author":"Uchino","year":"2011","journal-title":"Cancer"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"48586","DOI":"10.18632\/oncotarget.9374","article-title":"Simultaneous multitarget radiotherapy using helical tomotherapy and its combination with sorafenib for pulmonary metastases from hepatocellular carcinoma","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3748\/wjg.v21.i8.2336","article-title":"Biological effects of low-dose-rate irradiation of pancreatic carcinoma cells in vitro using 125I seeds","volume":"21","author":"Wang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/07357907.2014.905585","article-title":"Biological effects of (125) I seeds radiation on A549 lung cancer cells:G2\/M arrest and enhanced cell death","volume":"32","author":"Qu","year":"2014","journal-title":"Cancer Invest"},{"key":"R8-20241021","first-page":"2028","article-title":"Iodine-125 seed radiation induces ROS-mediated apoptosis, autophagy and paraptosis in human esophageal squamous cell carcinoma cells","volume":"43","author":"Wang","year":"2020","journal-title":"Oncol Rep"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"9230647","DOI":"10.1155\/2022\/9230647","article-title":"Iodine-125 seeds inhibit carcinogenesis of hepatocellular carcinoma cells by suppressing epithelial-mesenchymal transition via TGF-\u03b21\/Smad signaling","volume":"2022","author":"Yang","year":"2022","journal-title":"Dis Markers"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4103\/jcrt.JCRT_245_17","article-title":"Efficacy and safety of computed tomography-guided 125I brachytherapy for lymph node metastatic from hepatocellular carcinoma","volume":"14","author":"He","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4103\/jcrt.JCRT_750_17","article-title":"Clinical efficacy of computed tomography-guided iodine-125 seed implantation therapy for patients with metastatic epidural spinal cord compression:A retrospective study","volume":"15","author":"Liu","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4103\/jcrt.jcrt_1252_21","article-title":"Microwave ablation combined with I125 seed implantation for treatment of residual lesions of liver cancer after TACE","volume":"18","author":"Zhang","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1148\/radiol.2015150641","article-title":"Feasibility and clinical value of CT-guided (125) I brachytherapy for bilateral lung recurrences from colorectal carcinoma","volume":"278","author":"Wang","year":"2016","journal-title":"Radiology"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5114\/jcb.2017.67023","article-title":"Computed tomography-guided implantation of 125I seeds brachytherapy for recurrent multiple pulmonary oligometastases:Initial experience and results","volume":"9","author":"Li","year":"2017","journal-title":"J Contemp Brachytherapy"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"714006","DOI":"10.3389\/fendo.2021.714006","article-title":"Case report:Successful control of pulmonary metastatic pheochromocytoma with iodine-125 seed implantation","volume":"12","author":"Shi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.crad.2014.01.024","article-title":"CT-guided radioactive 125I seed implantation treatment of multiple pulmonary metastases of hepatocellular carcinoma","volume":"69","author":"Zhang","year":"2014","journal-title":"Clin Radiol"},{"key":"R17-20241021","first-page":"1549","article-title":"Chinese expert consensus workshop report:Guideline for permanent iodine-125 seeds implantation of primary and metastatic lung tumors (2020 edition)","volume":"16","author":"Zhang","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jcrt.jcrt_70_23","article-title":"SPACES:Our team's experience in lung tumor microwave ablation","volume":"19","author":"Wei","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.jvir.2016.08.013","article-title":"Local efficacy and survival after microwave ablation of lung tumors:A retrospective study in 183 patients","volume":"27","author":"Zheng","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5114\/jcb.2020.98112","article-title":"Iodine-125 seed implantation treatment of lung metastases<2.5 cm using 5-ml syringe as a guide","volume":"12","author":"Li","year":"2020","journal-title":"J Contemp Brachytherapy"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00432-019-02943-x","article-title":"Safety and efficacy of 125I brachytherapy for bilateral lung recurrences from hepatocellular carcinoma after resection or ablation","volume":"145","author":"Xiang","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5114\/jcb.2018.75598","article-title":"Percutaneous computed tomography-guided permanent 125I implantation as therapy for pulmonary metastasis","volume":"10","author":"Huo","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5114\/jcb.2019.82768","article-title":"How many times 125I seed implantation brachytherapy can be repeated for pulmonary metastases:Clinical efficacy and complications","volume":"11","author":"Li","year":"2019","journal-title":"J Contemp Brachyther"},{"key":"R25-20241021","article-title":"Clinicopathologic analysis of oral squamous cell carcinoma after 125I interstitial brachytherapy","volume":"17","author":"Jie","year":"2018","journal-title":"Technol Cancer Res T"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000477134","article-title":"Clinical factors predicting better survival outcome for pulmonary metastasectomy of hepatocellular carcinoma","volume":"6","author":"Kuo","year":"2017","journal-title":"Liver Cancer"},{"key":"R27-20241021","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s00268-020-05907-2","article-title":"Preoperative predictors of futile resection of intraabdominal extrahepatic metastases from hepatocellular carcinoma","volume":"45","author":"Linn","year":"2021","journal-title":"World J Surg"},{"key":"R28-20241021","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/02656736.2020.1775899","article-title":"Clinical outcomes of percutaneous thermal ablation for pulmonary metastases from hepatocellular carcinoma:A retrospective study","volume":"37","author":"Yuan","year":"2020","journal-title":"Int J Hyperthermia"},{"key":"R29-20241021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12957-021-02138-0","article-title":"Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method:Thoracoscopic versus open approach","volume":"19","author":"Lee","year":"2021","journal-title":"World J Surg Oncol"},{"key":"R30-20241021","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.dld.2016.06.007","article-title":"Iodine-125 implantation plus transarterial chemoembolization for the treatment of hepatocellular carcinoma of 3-5 cm:A propensity score matching study","volume":"48","author":"Li","year":"2016","journal-title":"Dig Liver Dis"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_519_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:22Z","timestamp":1787067682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_519_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_519_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"2022-03-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}